Effect of Different Alimentary Reconstruction for Gastrectomy on the Glu_cose Metabolism in Patients Complicated with Type 2 Diabetes
Dezhi BIAN,Xiangdong REN,Ke XU,Xiaojuan QIAN,Jiancheng YU
DOI: https://doi.org/10.3969/j.issn.1674-0742.2014.34.009
2014-01-01
Abstract:Objective To investigate the effects of different alimentary reconstruction for gastrectomy on the glucose metabolism in patients complicated with type 2 diabetes. Methods 100 cases who underwent radical surgery for gastric cancer complicated with type 2 diabetes in our hospital from March 2012 to March 2013 were divided into BillrothⅠ group (33 cases), BillrothⅡgroup(36 cases) and Roux-en-Y group (31 cases) according to different alimentary reconstruction. And the blood glucose levels of three groups before and after operation were analyzed comparatively and comprehensively. Results ①In BillrothⅠ group, there was no significant difference in levels of FBG and PG-2h before operation and 1 week, 1 month, 6 months after operation (P>0.05); ②In BillrothⅡ group, the levels of FBG before operation, 1 week, 1 month, 6 months after operation were (8.730 ±0.859)mmol/L, (7.328±0.706)mmol/L, (6.512±0.714)mmol/L, (6.802±0.813)mmol/L, respectively, and the levels of PG-2h before operation, 1 week, 1 month, 6 months after operation were (11.974±0.918)mmol/L, (7.429±1.432)mmol/L, (7.504±1.019)mmol/L, (7.657±2.033)mmol/L, respectively. In Roux-en-Y group, the levels of FBG before operation, 1 week, 1 month, 6 months after operation were (8.972± 0.843)mmol/L, (7.226 ±0.516)mmol/L, (6.468 ±0.533)mmol/L, (6.7042 ±0.721)mmol/L, respectively, and the levels of PG-2h before operation, 1 week, 1 month, 6 months after operation were (11.938±0.957)mmol/L, (7.024±1.917)mmol/L, (7.382±1.614)mmol/L, (7.665±1.953)mmol/L, respectively. In BillrothⅡ group and Roux-en-Y group, the levels of FBG and PG-2h 1 week, 1 month, 6 months after operation were much lower than those before operation (P<0.05). Conclusion Billroth II or Roux-en-Y type operation can effectively improve the postoperative glucose metabolism of gastric cancer patients with type 2 diabetes.